C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2004
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1165538B1 Process for the preparation of alpha-methylenelactones and alpha-substituted hydrocarbylidene lactones
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	CN1547576A Process for ascorbic acids using alkaline earth silicate catalysts
11/17/2004	CN1547570A Substituted c-cyclohexylmethylamine derivatives
11/17/2004	CN1546480A Process for preparing 5-alkyl-2-furfural alcohol
11/17/2004	CN1176058C Method for producing phthallic anhydride
11/16/2004	US6818782 Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
11/16/2004	US6818780 Application in medicine for treatment of disorders of immunological system
11/16/2004	US6818779 Thromboxane ligands without blood clotting side effects
11/16/2004	US6818765 Benzene-sulphonamide derivatives and their uses
11/16/2004	US6818670 Active ingredient combination having insecticidal and acaricidal characteristics
11/16/2004	US6818635 For therapy of bacterial infections and neoplasms,
11/11/2004	WO2004096945A1 1,3,6,8-tetrasubstituted pyrene compounds, organic el device and organic el display
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096787A1 Polycyclic lactones, (meth)acrylates having polycyclic lactone structures, and process for production thereof
11/11/2004	WO2004096786A1 Fluorinated cyclic compound, polymerizable fluoromonomer, fluoropolymer, resist material comprising the same, and method of forming pattern with the same
11/11/2004	WO2004096757A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	WO2004096198A1 Therapeutic agent
11/11/2004	WO2004075853A9 Halogenated triptolide derivatives as immunomodulators and anticancer agents
11/11/2004	WO2004052919A3 Peptide deformylase inhibitors
11/11/2004	WO2003078310A8 Method for the production of a catalyst containing vanadium, phosphorus, and oxygen
11/11/2004	US20040225136 Process for the preparation of 5-formylphthalide
11/11/2004	US20040225135 Method of producing optically active lactone compound
11/11/2004	US20040225121 Labeling using deuterium, tritium with catalyst
11/11/2004	US20040224994 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004	US20040223912 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	US20040223909 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/11/2004	CA2523677A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/10/2004	EP1475092A1 Blockers of the quorum sensing system of Gram-negative bacteria
11/10/2004	EP1474410A1 Process for the preparation of ascorbic acid
11/10/2004	EP1474388A1 Astaxanthin esters
11/10/2004	EP1474387A2 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation
11/10/2004	EP1474386A1 Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
11/10/2004	EP1474384A1 Beta-amino ketones for the treatment of pain
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1265880B1 Method for the preparation of citalopram
11/10/2004	EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/10/2004	EP1085009B1 Indan derivatives
11/10/2004	EP1027043B1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1545507A Lactone derivative, and plant growth regulator and rooting agent each containing the same as active ingredient
11/10/2004	CN1544424A 4-phenylacetylene benzoic anhydride preparation method
11/10/2004	CN1544423A Anti-tumour effective constituent cherimoya essence preparation method
11/10/2004	CN1174974C Synthesis of ester ether compound with high acidolysis activity
11/10/2004	CN1174973C Schizonepeta lactone and its extraction process and use
11/10/2004	CN1174972C Method for production of L-ascorbic acid by lactonization of 2-keto-L-gulonic acid or 2-keto-L-gulonate esters
11/10/2004	CN1174958C Purification process of keto acid
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815443 5-Amino-1-pentene-3-ol substituted derivatives
11/04/2004	WO2004094411A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
11/04/2004	WO2004094399A1 An improved process for the preparation of citalopram hydrobromide
11/04/2004	WO2004094398A2 Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide
11/04/2004	WO2004094376A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/04/2004	WO2004094369A2 Stabilized derivatives of ascorbic acid
11/04/2004	WO2004094362A1 CaSR ANTAGONIST
11/04/2004	WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004042351A3 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/04/2004	US20040220415 Benzofuran derivatives
11/04/2004	US20040220414 Process for making allyl succinic anhydride
11/04/2004	US20040220260 efficacious in producing nitric oxide in the skin, the mucous membranes or the scalp; treatment of psoriasis lesions and/or chronic ulcers; i.e. Ascorbyl 2-O-cinnamate
11/04/2004	US20040220253 Synthesis of pyrrole amides
11/04/2004	US20040220251 Furanose-type bicyclic carbohydrates with biological activity
11/04/2004	US20040220237 Asthma and allergic inflammation modulators
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	CA2523042A1 Stabilized derivatives of ascorbic acid
11/04/2004	CA2522687A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
11/04/2004	CA2522565A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/03/2004	EP1473291A1 Process for producing lactone
11/03/2004	EP1472536A2 Broad spectrum inhibitors
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472240A1 Drechslera anole derivatives, method for the production and use thereof
11/03/2004	EP1472239A1 Method for the preparation of enterolactone from matairesinol
11/03/2004	EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004	EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004	EP1472206A1 Lignan derivatives
11/03/2004	EP1421081A4 Method of mycophenolate mofetil preparation
11/03/2004	EP1373238B1 Alkylxanthates and their use as pesticides
11/03/2004	EP1317436B1 Gaseous acid catalysis
11/03/2004	EP1309582B1 Method for the preparation of citalopram
11/03/2004	EP1309581B1 Method for the preparation of citalopram
11/03/2004	EP1294677B1 Benzophenones and sulfones as inhibitors of glycine uptake
11/03/2004	EP1250331B1 Formulation for protection against oxidative stress containing benzofuranone derivatives
11/03/2004	EP1208094B1 Method for producing gamma-butyrolactone
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543453A 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)

1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 472